Wilhelm Ridderstråle

1.2k total citations · 1 hit paper
14 papers, 322 citations indexed

About

Wilhelm Ridderstråle is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Wilhelm Ridderstråle has authored 14 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 7 papers in Surgery and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Wilhelm Ridderstråle's work include Antiplatelet Therapy and Cardiovascular Diseases (7 papers), Cardiovascular Health and Disease Prevention (4 papers) and Blood Pressure and Hypertension Studies (4 papers). Wilhelm Ridderstråle is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (7 papers), Cardiovascular Health and Disease Prevention (4 papers) and Blood Pressure and Hypertension Studies (4 papers). Wilhelm Ridderstråle collaborates with scholars based in Sweden, United Kingdom and United States. Wilhelm Ridderstråle's co-authors include Þórdís Jóna Hrafnkelsdóttir, Sverker Jern, Kim Fox, Marielle Andersson, Shamir R. Mehta, Philippe Gabríel Steg, Anders Himmelmänn, Lawrence A. Leiter, Claes Held and Deepak L. Bhatt and has published in prestigious journals such as New England Journal of Medicine, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Wilhelm Ridderstråle

14 papers receiving 320 citations

Hit Papers

Ticagrelor in Patients with Stable Coronary Disease and D... 2019 2026 2021 2023 2019 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Ticagrelor in Patients with Stable Coronary Disease and Diabetes
    2019 204 citations Philippe Gabríel Steg, Deepak L. Bhatt et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wilhelm Ridderstråle Sweden 8 239 150 65 57 31 14 322
Mahn‐Won Park South Korea 14 330 1.4× 201 1.3× 46 0.7× 44 0.8× 14 0.5× 57 419
Olivija Gustienė Lithuania 12 225 0.9× 96 0.6× 43 0.7× 23 0.4× 40 1.3× 32 371
Αναστάσιος Κάρτας Greece 12 319 1.3× 75 0.5× 48 0.7× 29 0.5× 54 1.7× 61 442
Hillary Mulder United States 9 241 1.0× 99 0.7× 53 0.8× 24 0.4× 25 0.8× 15 376
Andrea Rivas United States 10 301 1.3× 152 1.0× 61 0.9× 75 1.3× 18 0.6× 20 375
Michael Stuart Garfinkle Canada 4 625 2.6× 61 0.4× 59 0.9× 51 0.9× 35 1.1× 5 721
Stéphane Rinfret Canada 8 220 0.9× 294 2.0× 56 0.9× 13 0.2× 23 0.7× 9 395
G. P. Molhoek Netherlands 10 274 1.1× 188 1.3× 65 1.0× 46 0.8× 17 0.5× 15 388
Hani Sabbour United Arab Emirates 11 176 0.7× 93 0.6× 84 1.3× 11 0.2× 45 1.5× 44 329
Shigeshi Kamikawa Japan 13 413 1.7× 138 0.9× 33 0.5× 37 0.6× 42 1.4× 34 501

Countries citing papers authored by Wilhelm Ridderstråle

Since Specialization
Citations

This map shows the geographic impact of Wilhelm Ridderstråle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wilhelm Ridderstråle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wilhelm Ridderstråle more than expected).

Fields of papers citing papers by Wilhelm Ridderstråle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wilhelm Ridderstråle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wilhelm Ridderstråle. The network helps show where Wilhelm Ridderstråle may publish in the future.

Co-authorship network of co-authors of Wilhelm Ridderstråle

This figure shows the co-authorship network connecting the top 25 collaborators of Wilhelm Ridderstråle. A scholar is included among the top collaborators of Wilhelm Ridderstråle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wilhelm Ridderstråle. Wilhelm Ridderstråle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Bonaca, Marc P., Deepak L. Bhatt, Tabassome Simon, et al.. (2024). Limb Outcomes With Ticagrelor Plus Aspirin in Patients With Diabetes Mellitus and Atherosclerosis. Journal of the American College of Cardiology. 83(17). 1627–1636. 4 indexed citations
2.
James, Stefan, David Erlinge, Robert F. Storey, et al.. (2023). Rationale and design of the DAPA-MI trial: Dapagliflozin in patients without diabetes mellitus with acute myocardial infarction. American Heart Journal. 266. 188–197. 12 indexed citations
3.
Steg, Philippe Gabríel, Deepak L. Bhatt, Stefan James, et al.. (2022). Cost–effectiveness of ticagrelor in patients with type 2 diabetes and coronary artery disease: a European economic evaluation of the THEMIS trial. European Heart Journal - Cardiovascular Pharmacotherapy. 8(8). 777–785. 2 indexed citations
4.
Leiter, Lawrence A., Deepak L. Bhatt, Darren K. McGuire, et al.. (2021). Diabetes-Related Factors and the Effects of Ticagrelor Plus Aspirin in the THEMIS and THEMIS-PCI Trials. Journal of the American College of Cardiology. 77(19). 2366–2377. 11 indexed citations
5.
6.
Steg, Philippe Gabríel, Deepak L. Bhatt, Stephanie James, et al.. (2020). Cost-effectiveness of ticagrelor in patients with type 2 diabetes and coronary artery disease with a history of PCI: an economic evaluation of THEMIS-PCI using a Swedish healthcare perpective. European Heart Journal. 41(Supplement_2). 1 indexed citations
7.
Bhatt, Deepak L., Kim Fox, Robert A. Harrington, et al.. (2019). Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study. Clinical Cardiology. 42(5). 498–505. 14 indexed citations
8.
Steg, Philippe Gabríel, Deepak L. Bhatt, Tabassome Simon, et al.. (2019). Ticagrelor in Patients with Stable Coronary Disease and Diabetes. New England Journal of Medicine. 381(14). 1309–1320. 204 indexed citations breakdown →
9.
Larsson, P., et al.. (2014). Profibrinolytic Effect of the Epigenetic Modifier Valproic Acid in Man. PLoS ONE. 9(10). e107582–e107582. 9 indexed citations
10.
Bergh, Niklas, Oskar Angerås, Per Albertsson, et al.. (2014). Does the timing of treatment with intra-aortic balloon counterpulsation in cardiogenic shock due to ST-elevation myocardial infarction affect survival?. Acute Cardiac Care. 16(2). 57–62. 12 indexed citations
11.
Ridderstråle, Wilhelm, et al.. (2011). The impaired fibrinolytic capacity in hypertension is unaffected by acute blood pressure lowering. Journal of Thrombosis and Thrombolysis. 32(4). 399–404. 5 indexed citations
12.
Ridderstråle, Wilhelm, et al.. (2009). Consistency of blood pressure and impact on cardiovascular structure over 20 years in young men. Journal of Internal Medicine. 267(3). 295–304. 3 indexed citations
13.
Ridderstråle, Wilhelm, Erik Ulfhammer, Sverker Jern, & Þórdís Jóna Hrafnkelsdóttir. (2006). Impaired Capacity for Stimulated Fibrinolysis in Primary Hypertension Is Restored by Antihypertensive Therapy. Hypertension. 47(4). 686–691. 30 indexed citations
14.
Ulfhammer, Erik, Wilhelm Ridderstråle, Maria Andersson, et al.. (2005). Prolonged cyclic strain impairs the fibrinolytic system in cultured vascular endothelial cells. Journal of Hypertension. 23(8). 1551–1557. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mahn‐Won Park Breakdown of academic impact, for papers by Olivija Gustienė Breakdown of academic impact, for papers by Αναστάσιος Κάρτας Breakdown of academic impact, for papers by Hillary Mulder Breakdown of academic impact, for papers by Andrea Rivas Breakdown of academic impact, for papers by Michael Stuart Garfinkle Breakdown of academic impact, for papers by Stéphane Rinfret Breakdown of academic impact, for papers by G. P. Molhoek Breakdown of academic impact, for papers by Hani Sabbour Breakdown of academic impact, for papers by Shigeshi Kamikawa
Rankless by CCL
2026